Lisdexamfetamine Contraindications UK: What Clinicians and Patients Need to Know

Lisdexamfetamine is a widely used ADHD medication, but it is not suitable for everyone. Before prescribing it, clinicians in the UK need to check for specific contraindications, medical risks, psychiatric cautions and medication interactions so treatment is both safe and appropriate.

This guide explains the main lisdexamfetamine contraindications in the UK, why they matter, what to screen for before prescribing, and what patients should know before starting treatment. It also includes a practical FAQ section for adult ADHD services, prescribers and patients.

What lisdexamfetamine is

Lisdexamfetamine is a stimulant medicine used to treat ADHD. It is commonly prescribed for adults when symptoms such as inattention, impulsivity and poor task completion are causing meaningful impairment. In UK practice, it is often one of the main first-line medication options for adult ADHD once the diagnosis has been confirmed and treatment is considered appropriate.

Because it is a stimulant, it can affect the cardiovascular system, appetite, sleep and mood. That is why a careful review of contraindications is essential before starting it.

Why contraindications matter

Contraindications are the conditions or circumstances where a medicine should not be used, or where it should only be used with great caution. In the case of lisdexamfetamine, the main concern is safety. The medication can raise blood pressure and pulse, may aggravate certain psychiatric conditions, and can interact with other drugs in ways that are dangerous if overlooked.

A good ADHD assessment does not stop at diagnosis. It also needs to check whether the treatment is suitable for the individual in front of the clinician. That is what makes lisdexamfetamine contraindications such an important part of adult ADHD care.

Main contraindications

The key lisdexamfetamine contraindications in the UK include:

  • Known hypersensitivity to lisdexamfetamine, amphetamine-type medicines, or excipients.

  • Concomitant or recent use of monoamine oxidase inhibitors (MAOIs), usually within 14 days.

  • Symptomatic cardiovascular disease.

  • Moderate to severe hypertension.

  • Advanced arteriosclerosis.

  • Hyperthyroidism or thyrotoxicosis.

  • Glaucoma.

  • Agitated states.

These are the conditions that should make a prescriber stop and reconsider before initiating treatment. In some cases, the issue is absolute; in others, it means specialist input is needed before any decision is made.

Cardiovascular risks

Cardiovascular safety is one of the biggest reasons lisdexamfetamine may be unsuitable. The medication can increase heart rate and blood pressure, so people with symptomatic cardiovascular disease, moderate to severe hypertension or serious rhythm problems need careful assessment.

If a patient has chest pain, syncope, a history of heart attack, heart failure or significant arrhythmia, the prescriber should not proceed casually. The risk-benefit discussion may need cardiology input or an alternative ADHD treatment. Baseline blood pressure and pulse should always be checked before treatment begins.

Psychiatric contraindications and cautions

Lisdexamfetamine can also be problematic in some psychiatric conditions. It may worsen agitation, anxiety, psychosis or manic symptoms in vulnerable patients. People with bipolar disorder, a history of psychosis, or significant agitation should be reviewed very carefully before treatment is started.

The same applies to patients with a history of tics or Tourette’s syndrome, because stimulants can sometimes make these symptoms worse. A family or personal history of mood instability does not automatically rule out ADHD treatment, but it does mean the prescriber must be more cautious.

Substance misuse and dependence

Another important consideration is substance misuse or dependence. Lisdexamfetamine is a controlled stimulant medicine, so a history of alcohol misuse, drug misuse or dependence requires careful review. This does not always mean the medication cannot be used, but it does mean the prescriber should assess risk, current stability and monitoring needs more closely.

Patients should also be advised not to use recreational drugs or alcohol in ways that could worsen side effects or make the medication less safe. In practice, this is one of the most important safety conversations in adult ADHD prescribing.

Eye conditions and endocrine concerns

Glaucoma is a key contraindication because stimulant medicines may worsen intraocular pressure and can potentially aggravate angle-closure risk. This is why eye history matters, especially where there is known glaucoma or susceptibility to it.

Hyperthyroidism or thyrotoxicosis is also important because stimulant effects can be amplified when the body is already in a hyperadrenergic state. A patient with uncontrolled thyroid disease should be reviewed and stabilised appropriately before considering lisdexamfetamine.

Medication interactions

Lisdexamfetamine should not be used with MAOIs or within 14 days of stopping an MAOI because of the risk of serious hypertensive crisis. That interaction is one of the most important and well-established contraindications.

Other medicines may also require caution, particularly those affecting blood pressure, serotonin pathways or cardiovascular function. This is why a full medication history, including over-the-counter treatments and supplements, is essential before prescribing.

Pregnancy and breastfeeding

Pregnancy and breastfeeding are not always absolute contraindications in every situation, but they do require specialist discussion. If a patient is pregnant, planning pregnancy or breastfeeding, the prescriber should review the risks and benefits carefully and consider whether treatment should continue, pause or change.

In UK adult ADHD services, any pregnancy planning should be flagged early because medication decisions may need to be reconsidered as circumstances change.

What to check before prescribing

A safe pre-prescribing review for lisdexamfetamine should include:

  • Blood pressure and pulse.

  • Weight.

  • Cardiovascular history.

  • Psychiatric history.

  • Substance misuse history.

  • Eye history, especially glaucoma.

  • Thyroid history.

  • Current medication list.

  • Pregnancy and breastfeeding status.

  • Family history of heart disease, bipolar disorder or sudden cardiac problems.

This is not just paperwork. It is what helps identify whether the medication is appropriate and whether a different treatment may be safer.

Why a proper ADHD assessment matters

Lisdexamfetamine should only be considered after a proper ADHD assessment has confirmed the diagnosis and explored whether treatment is appropriate. A rushed prescription without screening can miss serious risks.

A good assessment also helps separate ADHD from conditions that can look similar, such as anxiety, depression, burnout or sleep problems. That matters because if the real problem is something else, the medication may not help and may even make things worse.

What patients should tell their prescriber

If you are being assessed for lisdexamfetamine, you should tell your prescriber about:

  • Any heart problems or high blood pressure.

  • Any history of glaucoma.

  • Any thyroid condition.

  • Any previous episodes of mania, psychosis or severe anxiety.

  • Any seizures or epilepsy.

  • Any tics or Tourette’s syndrome.

  • Any substance or alcohol misuse.

  • Any pregnancy plans or breastfeeding.

  • Any current medicines or supplements.

The more accurate the history, the safer the treatment decision will be.

Frequently Asked Questions

What are the main lisdexamfetamine contraindications in the UK?

The main contraindications include hypersensitivity to the medicine, recent MAOI use, symptomatic cardiovascular disease, moderate to severe hypertension, advanced arteriosclerosis, hyperthyroidism, glaucoma and agitated states. These should be checked before prescribing.

Can lisdexamfetamine be used if I have anxiety?

Possibly, but it depends on the severity and pattern of the anxiety. Anxiety alone does not automatically rule out treatment, but the prescriber should review whether stimulant medication might worsen agitation, insomnia or panic symptoms.

Is lisdexamfetamine safe if I have high blood pressure?

It depends on the severity and whether the blood pressure is controlled. Moderate to severe hypertension is a contraindication, so this must be reviewed carefully before treatment starts.

Can I take lisdexamfetamine if I have bipolar disorder?

It may be possible in some cases, but the risk of triggering mania or mood instability means the prescriber needs to be very cautious. Specialist review is usually needed before treatment is started.

Why is glaucoma a contraindication?

Lisdexamfetamine may increase the risk of worsening eye pressure in people with glaucoma or susceptibility to angle-closure glaucoma. That is why eye history must be checked before prescribing.

What if I am pregnant or breastfeeding?

You should tell your prescriber immediately. Lisdexamfetamine use in pregnancy or breastfeeding needs an individual risk-benefit review, and treatment may need to be changed or paused depending on your situation.

Final thoughts

Lisdexamfetamine can be an effective ADHD treatment, but it is not suitable for everyone. The UK contraindications are there to protect patients by making sure cardiovascular, psychiatric and medication risks are identified before treatment begins.

A careful assessment is not a barrier to care. It is what makes ADHD treatment safer, more personalised and more likely to succeed. For patients, that means better-informed decisions and a clearer understanding of whether lisdexamfetamine is the right option.

If you are considering ADHD medication, book a proper assessment first so contraindications, risks and treatment options can be reviewed safely. At Focus Gently, we offer structured ADHD assessments and medication reviews designed to support safe, evidence-based prescribing.

Next
Next

Weiss ADHD Review Tool: A Practical Guide for Adult ADHD Assessment